Mechanisms of Tumor Radiosensitization: A Perspective of Nano‐Radiotherapy
WIREs Nanomedicine and Nanobiotechnology · 2025
DOI: 10.1002/wnan.70035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2025. Verfasst von Jiangwei Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Imaging, ShouGang ShuiGang Hospital, Liupanshui, China. Hauptthemen laut MEDLINE: Neoplasms, Radiation-Sensitizing Agents, Nanomedicine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 130 Literaturangaben. Gefördert von: the Health Commission of Heilongjiang Province, HMU Marshal Initiative Funding and the special funding from the Fourth Affiliated Hospital of Harbin Medical University, Health Commission of Heilongjiang Province.
Abstract (Originalsprache)
Radiotherapy (RT) is one of the cornerstones in cancer treatment, with approximately 50% of patients receiving radiation regimens annually. However, its clinical efficacy is constrained by two persistent challenges: tumor radioresistance and radiation‐induced damage to healthy tissues. Recent advances in nanomedicine have yielded innovative nano‐radiosensitizers capable of enhancing tumor‐specific radiation dose deposition while sparing normal tissues, thereby addressing both limitations simultaneously. Previous advanced reviews have extensively covered intrinsic nanomaterial properties and physicochemical mechanisms of radiosensitization; this review systematically elucidates radiosensitization mechanisms through the lens of RT subprocesses, offering a novel framework to evaluate how specific mechanisms modulate discrete stages of radiation response. It includes increasing radiation dose deposition; lowering antioxidant system level to promote ROS production; collaborating with other ways to promote ROS production; collaborating with the production of exogenous cytotoxic substances; augmenting intrinsic radiosensitivity of cancer cells; stabilizing radiation‐induced DNA lesions to suppress repair machinery; and enhancing radiogenic immunogenic cell death to strengthen antitumor immunity. Furthermore, we discuss emerging trends in nanotechnology‐driven combination therapies. This systematic perspective advances the rational design of next‐generation nano‐radiosensitizers and informs personalized radiotherapy protocols. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Imaging, ShouGang ShuiGang Hospital, Liupanshui, China.
- Molecular Imaging Center and Department of Nuclear Medicine, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
- Department of Health Policy and Management, Nippon Medical School, Tokyo, Japan.
ORCID-Profile: Jiangwei Zhou
Förderung
- the Health Commission of Heilongjiang Province
- HMU Marshal Initiative Funding and the special funding from the Fourth Affiliated Hospital of Harbin Medical University
- Health Commission of Heilongjiang Province
Zitieren
APA
Zhou, J., Zhang, Y., Dong, F., Matsuyama, K., Tanaka, Y., & Wu, L. (2025). Mechanisms of Tumor Radiosensitization: A Perspective of Nano‐Radiotherapy. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.70035
Vancouver
Zhou J, Zhang Y, Dong F, Matsuyama K, Tanaka Y, Wu L. Mechanisms of Tumor Radiosensitization: A Perspective of Nano‐Radiotherapy. WIREs Nanomedicine and Nanobiotechnology. 2025. doi:10.1002/wnan.70035
BibTeX
@article{Zhou2025,
author = {Zhou, Jiangwei and Zhang, Yongcheng and Dong, Fushi and Matsuyama, Kotone and Tanaka, Yosuke and Wu, Lina},
title = {Mechanisms of Tumor Radiosensitization: A Perspective of Nano‐Radiotherapy},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2025},
doi = {10.1002/wnan.70035}
}
EUVIMED